Literature DB >> 13876240

Effect of alpha-methyl DOPA in severe and malignant hypertension.

P J CANNON, R T WHITLOCK, R C MORRIS, M ANGERS, J H LARAGH.   

Abstract

Entities:  

Keywords:  DOPA/related compounds; HYPERTENSION/therapy

Mesh：

Substances：

Year:  1962        PMID： 13876240     DOI： 10.1001/jama.1962.03050090001001

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  21 in total

1.  GUANETHIDINE AND METHYLDOPA: A HAEMODYNAMIC STUDY.

Authors:  D A CHAMBERLAIN; J HOWARD
Journal:  Br Heart J       Date:  1964-07

2.  [EFFECT OF THE DOPA-DECARBOXYLASE INHIBITOR ALPHA-METHYLDOPA ON THE INCORPORATION OF DOPA INTO MELANIN AND PYROCATECHOLAMINE. IN VIVO STUDIES ON MELANOMA MICE WITH TRITIATED DOPA].

Authors:  K HEMPEL; M DEIMEL
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1963-11-08

3.  [The effect of intravenously administered DOPA on the blood pressure in pretreated alpha-methyl-DOPA hypertensives. Studies on the blood pressure-lowering mechanism of alpha-methyl-DOPA].

Authors:  H SCHAER; W H ZIEGLER
Journal:  Klin Wochenschr       Date:  1962-09-15

4.  Bethanidine, Guanethidine, and Methyldopa in Treatment of Hypertension: a Within-patient Comparison.

Authors:  B N Prichard; A W Johnston; I D Hill; M L Rosenheim
Journal:  Br Med J       Date:  1968-01-20

5.  Methyldopa.

Authors: 
Journal:  Br Med J       Date:  1962-06-16

6.  Methyldopa in the Treatment of Hypertension.

Authors:  P Lauwers; M Verstraete; J V Joossens
Journal:  Br Med J       Date:  1963-02-02

7.  To-day's Drugs.

Authors: 
Journal:  Br Med J       Date:  1963-04-13

8.  Alpha-Methyl DOPA and Hypertension.

Authors: 
Journal:  Can Med Assoc J       Date:  1962-08-04       Impact factor: 8.262

9.  Aspects of the biogenic amine-depleting activity of ethyl 3-acetamido-4H-pyrrolo-[3,4-c]isoxazole-5(6H)-carboxylate in the rat.

Authors:  W Lippmann; M Wishnick
Journal:  Br J Pharmacol Chemother       Date:  1968-06

Review 10.  Clinical pharmacokinetics of methyldopa.

Authors:  E Myhre; H E Rugstad; T Hansen
Journal:  Clin Pharmacokinet       Date:  1982 May-Jun       Impact factor: 6.447
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.